Logo image of CBAT

CBAK ENERGY TECHNOLOGY INC (CBAT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CBAT - US14986C1027 - Common Stock

0.8351 USD
-0.02 (-1.87%)
Last: 12/31/2025, 8:00:02 PM
0.8469 USD
+0.01 (+1.41%)
After Hours: 12/31/2025, 8:00:02 PM
Fundamental Rating

3

CBAT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 91 industry peers in the Electrical Equipment industry. Both the profitability and financial health of CBAT have multiple concerns. CBAT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CBAT had negative earnings in the past year.
CBAT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CBAT reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CBAT reported negative operating cash flow in multiple years.
CBAT Yearly Net Income VS EBIT VS OCF VS FCFCBAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

With a decent Return On Assets value of -1.79%, CBAT is doing good in the industry, outperforming 62.64% of the companies in the same industry.
CBAT's Return On Equity of -5.36% is fine compared to the rest of the industry. CBAT outperforms 63.74% of its industry peers.
Industry RankSector Rank
ROA -1.79%
ROE -5.36%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
CBAT Yearly ROA, ROE, ROICCBAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

CBAT's Profit Margin has declined in the last couple of years.
The Gross Margin of CBAT (14.07%) is worse than 64.84% of its industry peers.
In the last couple of years the Gross Margin of CBAT has grown nicely.
The Profit Margin and Operating Margin are not available for CBAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
CBAT Yearly Profit, Operating, Gross MarginsCBAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

2

2. Health

2.1 Basic Checks

CBAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CBAT remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CBAT has more shares outstanding
Compared to 1 year ago, CBAT has an improved debt to assets ratio.
CBAT Yearly Shares OutstandingCBAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CBAT Yearly Total Debt VS Total AssetsCBAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -0.18, we must say that CBAT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.18, CBAT is in line with its industry, outperforming 48.35% of the companies in the same industry.
A Debt/Equity ratio of 0.29 indicates that CBAT is not too dependend on debt financing.
CBAT's Debt to Equity ratio of 0.29 is fine compared to the rest of the industry. CBAT outperforms 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z -0.18
ROIC/WACCN/A
WACC5.68%
CBAT Yearly LT Debt VS Equity VS FCFCBAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CBAT has a Current Ratio of 0.69. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CBAT (0.69) is worse than 82.42% of its industry peers.
A Quick Ratio of 0.54 indicates that CBAT may have some problems paying its short term obligations.
CBAT has a Quick ratio of 0.54. This is in the lower half of the industry: CBAT underperforms 78.02% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.54
CBAT Yearly Current Assets VS Current LiabilitesCBAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The earnings per share for CBAT have decreased strongly by -141.18% in the last year.
The earnings per share for CBAT have been decreasing by -42.83% on average. This is quite bad
The Revenue for CBAT has decreased by -22.02% in the past year. This is quite bad
CBAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.40% yearly.
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%

3.2 Future

The Earnings Per Share is expected to decrease by -11.42% on average over the next years. This is quite bad
CBAT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.48% yearly.
EPS Next Y-139.23%
EPS Next 2Y-11.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.19%
Revenue Next 2Y30.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CBAT Yearly Revenue VS EstimatesCBAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CBAT Yearly EPS VS EstimatesCBAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.05 -0.05 0.1 0.15

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CBAT. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 8.19 indicates a reasonable valuation of CBAT.
Based on the Price/Forward Earnings ratio, CBAT is valued cheaply inside the industry as 97.80% of the companies are valued more expensively.
CBAT is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 8.19
CBAT Price Earnings VS Forward Price EarningsCBAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBAT Per share dataCBAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A cheap valuation may be justified as CBAT's earnings are expected to decrease with -11.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.42%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBAT!.
Industry RankSector Rank
Dividend Yield 0%

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (12/31/2025, 8:00:02 PM)

After market: 0.8469 +0.01 (+1.41%)

0.8351

-0.02 (-1.87%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-10 2025-11-10/bmo
Earnings (Next)03-16 2026-03-16/bmo
Inst Owners2.69%
Inst Owner Change25.15%
Ins Owners16.97%
Ins Owner Change0%
Market Cap74.03M
Revenue(TTM)161.76M
Net Income(TTM)-6.51M
Analysts0
Price Target1.53 (83.21%)
Short Float %0.22%
Short Ratio0.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)26.47%
Max EPS beat(2)173.53%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)35.26%
Min Revenue beat(2)18.4%
Max Revenue beat(2)52.11%
Revenue beat(4)2
Avg Revenue beat(4)-3.55%
Min Revenue beat(4)-50.36%
Max Revenue beat(4)52.11%
Revenue beat(8)2
Avg Revenue beat(8)-9.8%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)58.33%
EPS NY rev (3m)58.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)53.29%
Revenue NY rev (1m)28.12%
Revenue NY rev (3m)28.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.19
P/S 0.46
P/FCF N/A
P/OCF 2.6
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)0.1
Fwd EY12.21%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.32
OCFY38.43%
SpS1.82
BVpS1.37
TBVpS1.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.79%
ROE -5.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.07%
FCFM N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 509.98%
Cap/Sales 22.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.54
Altman-Z -0.18
F-Score2
WACC5.68%
ROIC/WACCN/A
Cap/Depr(3y)245.38%
Cap/Depr(5y)296.85%
Cap/Sales(3y)10.68%
Cap/Sales(5y)16.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-139.23%
EPS Next 2Y-11.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%
Revenue Next Year-0.19%
Revenue Next 2Y30.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-149.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.57%
OCF growth 3YN/A
OCF growth 5YN/A

CBAK ENERGY TECHNOLOGY INC / CBAT FAQ

What is the fundamental rating for CBAT stock?

ChartMill assigns a fundamental rating of 3 / 10 to CBAT.


What is the valuation status of CBAK ENERGY TECHNOLOGY INC (CBAT) stock?

ChartMill assigns a valuation rating of 2 / 10 to CBAK ENERGY TECHNOLOGY INC (CBAT). This can be considered as Overvalued.


How profitable is CBAK ENERGY TECHNOLOGY INC (CBAT) stock?

CBAK ENERGY TECHNOLOGY INC (CBAT) has a profitability rating of 2 / 10.


Can you provide the financial health for CBAT stock?

The financial health rating of CBAK ENERGY TECHNOLOGY INC (CBAT) is 2 / 10.